May 17, 2013

Nitrosigine™ FDA NDI Accepted

Nutrition 21, LLC, Purchase, NY, a developer and marketer of nutritional ingredients, has launched of Nitrosigine, a novel patented source of inositol-stabilized arginine silicate accepted by the United States Food and Drug Administration (FDA) as a New Dietary Ingredient (NDI). In pre-clinical studies, Nitrosigine has been shown to demonstrate superiority over arginine in blood flow markers and has been shown to positively affect silicon absorption, providing evidence of health benefits applicable to many market categories.

more news

MORE NEWS
Get in Touch

500 Mamaroneck AveSuite 510Harrison, NY 10528

Nutrition21 Proudly Supports the Following Industry Associations

Association 6050 Uai Nutrition21

©2020 Nutrition21, LLC. All rights reserved.       

Nitrosigine®, Velositol®, nooLVL®, Chromax®, Lepidamax®, Zinmax®, and their associated logos are registered trademarks of Nutrition21, LLC.  All third party trademarks are the property of their respective owners. Nutrition21, LLC's products are protected by a number of patents including, but not limited to: US Patent Nos. 6,809,115; 6,803,456; 7,576,132; 8,062,677; 8,933,022; 9,005,637; 9,028,879; 9,119,835; 9,421,170; 9,597,404; 9,675,702; 10,183,049; 10,245,325; and 10,363,222.

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.